-
New Horizon Health Registers Three Medical Devices in Hong Kong’s Department of Health
•
Hangzhou-based New Horizon Health Ltd (HKG: 6606) has announced the successful registration of three of its medical products with the Department of Health in the Hong Kong Special Administrative Region, facilitated through the Medical Device Administrative Control System (MDACS). This development marks a significant expansion of the company’s reach and…
-
Takeda Partners with New Horizon Health Technology to Manage Helicobacter pylori in China
•
At the 6th China International Import Expo (CIIE) in Shanghai, Japan-based Takeda has inked a partnership with China-based New Horizon Health Technology Co., Ltd (HKG: 6606), a leading cancer diagnostics developer. The collaboration aims to develop a comprehensive management solution for Helicobacter pylori patients in China, underscoring Takeda’s (TYO: 4502)…
-
New Horizon Health Ltd Reports 264.6% YOY Revenue Increase and First Recurring Profits
•
China-based New Horizon Health Ltd (HKG: 6606), a leading cancer diagnostics developer, has released its audited interim financial report for the period ended June 30, 2023. The company reported revenues of RMB 820 million (USD 112 million), marking a significant increase of 264.6% year-on-year (YOY). This period also saw the…
